TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer
NCT02794337
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
67
Enrollment
OTHER_GOV
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
RADIATION:
SBRT
PROCEDURE:
TACE
DRUG:
Sorafenib
Sponsor
Tata Memorial Hospital